Qube Research & Technologies (QRT)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $658M | Buy |
715,082
+518,960
| +265% | +$526M | 0.73% | 5 |
|
|
2025
Q4 | $211M | Buy |
+196,122
| New | +$188M | 0.21% | 86 |
|
|
2025
Q3 | – | Sell |
-28,440
| Closed | -$21.2M | – | 3807 |
|
|
2025
Q2 | $22.2M | Sell |
28,440
-162,661
| -85% | -$126M | 0.02% | 821 |
|
|
2025
Q1 | $158M | Buy |
191,101
+11,333
| +6% | +$9.43M | 0.18% | 129 |
|
|
2024
Q4 | $139M | Sell |
179,768
-34,067
| -16% | -$28.2M | 0.18% | 132 |
|
|
2024
Q3 | $189M | Sell |
213,835
-115,722
| -35% | -$104M | 0.28% | 58 |
|
|
2024
Q2 | $298M | Buy |
329,557
+157,288
| +91% | +$126M | 0.47% | 26 |
|
|
2024
Q1 | $134M | Sell |
172,269
-187,660
| -52% | -$134M | 0.21% | 109 |
|
|
2023
Q4 | $210M | Sell |
359,929
-55,544
| -13% | -$32.4M | 0.41% | 38 |
|
|
2023
Q3 | $223M | Buy |
+415,473
| New | +$214M | 0.58% | 20 |
|
|
2022
Q4 | – | Sell |
-61,710
| Closed | -$21.9M | – | 2775 |
|
|
2022
Q3 | $20M | Buy |
61,710
+27,095
| +78% | +$8.58M | 0.12% | 238 |
|
|
2022
Q2 | $11.2M | Sell |
34,615
-114,161
| -77% | -$34.3M | 0.08% | 298 |
|
|
2022
Q1 | $42.6M | Buy |
+148,776
| New | +$38.3M | 0.36% | 43 |
|
|
2021
Q4 | – | Sell |
-93,983
| Closed | -$21.7M | – | 2770 |
|
|
2021
Q3 | $21.7M | Buy |
93,983
+23,435
| +33% | +$5.78M | 0.27% | 68 |
|
|
2021
Q2 | $16.2M | Sell |
70,548
-4,425
| -6% | -$889K | 0.18% | 109 |
|
|
2021
Q1 | $14M | Buy |
74,973
+17,408
| +30% | +$3.41M | 0.22% | 78 |
|
|
2020
Q4 | $9.72M | Sell |
57,565
-80,797
| -58% | -$12.1M | 0.14% | 159 |
|
|
2020
Q3 | $20.5M | Buy |
138,362
+108,511
| +364% | +$16.8M | 0.29% | 60 |
|
|
2020
Q2 | $4.9M | Buy |
29,851
+28,248
| +1,762% | +$4.34M | 0.07% | 360 |
|
|
2020
Q1 | $222K | Buy |
+1,603
| New | +$220K | 0.01% | 834 |
|
|
2019
Q4 | – | Sell |
-3,629
| Closed | -$406K | – | 1557 |
|
|
2019
Q3 | $406K | Sell |
3,629
-9,247
| -72% | -$1.03M | 0.27% | 111 |
|
|
2019
Q2 | $1.43M | Sell |
12,876
-32,950
| -72% | -$3.88M | 0.34% | 79 |
|
|
2019
Q1 | $5.95M | Buy |
45,826
+43,004
| +1,524% | +$5.23M | 0.79% | 27 |
|
|
2018
Q4 | $327K | Sell |
2,822
-10,357
| -79% | -$1.16M | 0.14% | 184 |
|
|
2018
Q3 | $1.41M | Buy |
13,179
+12,814
| +3,511% | +$1.28M | 0.19% | 91 |
|
|
2018
Q2 | $31K | Sell |
365
-694
| -66% | -$57K | 0.02% | 643 |
|
|
2018
Q1 | $81K | Buy |
+1,059
| New | +$85.3K | 0.03% | 245 |
|
Other funds holding LLY
VCM
VPM
Qube Research & Technologies (QRT)'s LLY Position: Q1 2026 in Review
Qube Research & Technologies (QRT) increased its Eli Lilly (LLY) stake by 265% in Q1 2026, buying an estimated $526M and bringing the position to 715,082 shares worth $658M. The position accounts for 0.73% of the portfolio, ranked #5.
Qube Research & Technologies (QRT) first reported a position in LLY in Q1 2018 and has held it in 27 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Qube Research & Technologies (QRT) held 715,082 shares of Eli Lilly worth $658M as of Q1 2026.
- Qube Research & Technologies (QRT) bought 518,960 Eli Lilly shares in Q1 2026, an estimated $526M.
- Eli Lilly made up 0.73% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #5 holding.
- Qube Research & Technologies (QRT) first reported a position in Eli Lilly in Q1 2018 and has held it in 27 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.